Latest news in the pet health supplement industry in 2026

I. Overall Industry Overview: Stable Growth, Pet Supplements Become Core Profit Track

The overall domestic pet consumption market exceeded 300 billion yuan in 2026, maintaining steady double-digit growth. With the increasing awareness of professional and refined pet care among pet owners, the industry has shifted from simply “feeding and raising well” to “health care and disease prevention.”

Among them, the pet supplement track saw the fastest growth, with the annual market size exceeding 22 billion yuan. Its gross profit margin is far higher than that of staple food and snacks, making it the most stable, profitable, and highest-repurchase-rate segment in the pet industry. The aging of pets, the increase in sterilization rates, and the high incidence of stress problems have driven the demand for functional pet care products.

II. Key Industry Events in 2026: The Year of Industry Compliance Reshuffling

2026 was unanimously recognized by the industry as the first year of strong compliance in the pet industry. Multiple departments jointly rectified the situation, completely eliminating small workshops and white-label products, and rapidly concentrating production capacity in leading GMP-certified factories.

1. New National Standards for Pet Food Officially Implemented in May: The new national standards for pet food issued by the Ministry of Agriculture and Rural Affairs are fully implemented, unifying the quality standards for staple foods, snacks, and nutritional supplements. Strict regulations govern ingredient labeling, content, and production standards, leading to the complete removal of substandard and falsely labeled products from the market.

2. Comprehensive Special Rectification of Medical, Boarding, and Health Supplement Products Starting in June: Nationwide crackdowns on unlicensed production, false efficacy claims, and the misuse of veterinary drug/health supplement licenses. Small factories without laboratories, testing reports, or GMP facilities are being phased out en masse, while the advantages of compliant, self-developed, and certified large manufacturers are being amplified.

3. Efficacy Claims Now Fully Verifiable: All claims of joint protection, urinary tract health, immune enhancement, liver and heart protection, etc., must be supported by third-party animal testing reports and complete testing data. The industry has officially entered an era of data-driven and technologically competitive practices, moving beyond mere verbal claims.

III. 2026 Top-Selling Product Trends (High-Growth Essential Needs)
This year, the top-grossing product categories are all concentrated in the **Functional Pet Care** category, which is also currently the category with the largest shipment volume for OEM and branded products:

1. Senior Pet Anti-Aging Care: With over 30 million middle-aged and senior dogs and cats nationwide, joint degeneration, functional decline, and heart aging issues are emerging, making nutritional products specifically for senior pets the biggest trend of the year.

2. Pet Joint Care: Annual growth rate of 130%, UC-II, green-lipped mussel, and chondroitin formulas have become high-end standard, with granule formulations having the highest repurchase rate among families.

3. Urinary Tract Care: Essential for spayed/neutered male and female cats, cranberry-based lactose-free nutritional paste continues to sell well, with online and cross-border orders surging.

4. Immune and Post-Operative Rehabilitation: Lactoferrin and compound immune formulas have become essential products for attracting customers to stores, with stable demand from puppies, postpartum, and post-illness recovery.

5. High-End Krill Fish Oil: Replacing traditional fish oil, astaxanthin + high absorption properties have become the mainstream upgraded product in the market. IV. Product Dosage Form Consumption Trends (Mainstream Bestseller Forms in 2026)

1. Lactose-Free Syringe Nutritional Paste: Convenient to feed, lactose-free and does not cause diarrhea, suitable for dogs and cats of all ages, the highest conversion rate dosage form in e-commerce, cross-border e-commerce, and pet stores.

2. Large-Can Functional Granules: High cost-performance ratio, a necessity for family stockpiling, extremely high repurchase rate, suitable for distribution, wholesale, and private domain channels.

3. Soft Capsule Formulation: Fish oil, probiotics, immune capsules, high-end appearance, minimalist and clean design, suitable for cross-border e-commerce and high-end brand positioning.

V. Channel Trends: Domestic Competition, Cross-Border Explosion

1. Domestic Channels: Compliance is King
Douyin, JD.com, and Pinduoduo are strictly investigating false advertising. Brands prioritize cooperation with source factories that have GMP workshops, laboratories, complete reports, and patents. Small workshops and OEM manufacturing are completely eliminated.

2. Explosive Growth in Cross-Border Channels
2026 saw a boom in overseas sales of pet health products, with orders from Southeast Asia, the Middle East, and Europe and the United States continuing to rise. Overseas platforms preferred products from reputable factories with 0% lactose formula, clean labels, no unnecessary additives, and complete testing reports. Domestic pet health product brands are entering a period of large-scale overseas expansion and significant profits.

VI. Changes in the Industry Competitive Landscape
1. The industry has moved beyond price wars and entered an era of competition based on R&D, quality control, compliance, and technology.

2. Industry concentration is rapidly increasing, with production capacity, orders, and brand resources concentrating on leading GMP-certified high-tech enterprises.

3. Customers are no longer looking for the “cheapest factory,” but instead choosing the “most stable, compliant, safe, and long-term cooperative” high-tech factories at the source.

VII. Summary of Industry Benefits for Reputable Large Manufacturers (Huashengweike)

1. Strict compliance and regulation have eliminated many small workshops in the industry, significantly releasing market potential;

2. The senior pet, joint, urinary, and immune systems sectors are experiencing explosive growth, highly aligning with the company’s product portfolio;

3. The cross-border e-commerce market is opening up, allowing companies with FDA, GMP, and full-form dosage form production capacity to exclusively enjoy foreign trade benefits;

4. R&D strength, testing laboratories, patented technologies, and digital production capacity have become core competitive advantages for attracting investment, maximizing the advantages of reputable high-tech enterprises.